Hubei Goto Biopharm Group Co., Ltd. (SHE:300966)
China · Delayed Price · Currency is CNY 24.15
-0.45 (-1.83%)
Oct 14, 2026, 12:00 PM CST
Hubei Goto Biopharm Group Market Cap
Hubei Goto Biopharm Group has a market cap or net worth of 2.76 billion as of October 13, 2026. It is the 16,187th most valuable company in the world and the 4,452nd biggest in China. Its market cap has increased by 11.22% in one year.
Market Cap
2.76B
Enterprise Value
4.08B
Revenue
650.05M
Global Rank
Country Rank
#4,452 China
PE Ratio
n/a
ChartMarket Cap Chart
Since April 9, 2021, Hubei Goto Biopharm Group's market cap has decreased from 6.57B to 2.76B, a decrease of -58.02%. That is a compound annual growth rate of -14.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 2.76B | 21.72% |
| Dec 31, 2025 | 2.27B | 21.86% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
| Apr 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guanhao Biotech | 3.25B |
| Baolingbao Biology | 3.22B |
| Zhejiang East Asia Pharmaceutical | 3.18B |
| Hinova Pharmaceuticals | 3.18B |
| Shanghai Universal Biotech | 3.10B |
| Beijing Kawin Technology Share-Holding | 3.07B |
| Zhejiang Shouxiangu Pharmaceutical | 2.95B |
| Yantai Zhenghai Biotechnology | 2.85B |